The newest Spider-Man movie did something that no other movie released during the pandemic era could. Spider-Man: No Way Home officially grossed $1.05 billion at the box office worldwide, Variety confirmed. Not only does that makes it the highest-grossing film of the pandemic era, but also the first movie that joined a billion dollar club ever since the pandemic began in March 2020. Also, Spider-Man: No Way Home is the first movie that grossed more than a billion dollars since Star Wars: The Rise of Skywalker, which was released in December 2019.
It’s known that the pandemic of COVID-19 made a huge negative impact on theaters and the movie industry in general. Many movies that were about to be released were delayed, moved to the streaming services, or released simultaneously in theaters and on VOD platforms. The industry started recovering last summer when F9 earned $726 million, and No Time To Dieearned $774 million last October. Although these are pretty good numbers, it’s still below expectations considering the huge popularity that these two franchises have. Still, these two movies were the two highest-grossing American movies of the pandemic era.
Two Chinese movies — The Battle at Lake Changjin and Hi, Mom, earned even more ($902 million and $822 million, respectively). But now, No Way Home surpassed all of them. No Way Home is currently the second highest-grossing movie Sony ever released. Its predecessor, Spider: Far From Home, which grossed $1.131 billion, is still the first one, but it’s likely that No Way Home will take over the first place.
Directed by Jon Watts, Spider-Man: No Way Home is the 27th movie set in the Marvel Cinematic Universe. The movie concluded the Spider-Man Home trilogy starring Tom Holland. Although Tom Holland still didn’t give a definitive answer on will he return as the web-slinger, producers Kevin Feige and Amy Pascal announced that the development of Spider-Man 4 is already underway, with Pascal saying they plan to make one more Spider-Man trilogy set in the Marvel Cinematic Universe.